Nabeshima T, Ishikawa K, Yamaguchi K, Furukawa H, Kameyama T
Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Meijo University, Nagoya, Japan.
Biochem Pharmacol. 1988 Sep 1;37(17):3277-83. doi: 10.1016/0006-2952(88)90639-9.
We investigated whether phencyclidine (PCP)-induced head-twitch was antagonized in rats by ritanserin, a selective serotonin2 (5-HT2) receptor antagonist, to confirm the involvement of 5-HT neurons in PCP action and to discover whether PCP could protect the binding sites of [3H]PCP and [3H]ketanserin from the inhibitory effect of protein-modifying reagents which affect sulfhydryl groups. PCP (7.5, 10 and 12.5 mg/kg, i.p.)-induced head-twitch was completely antagonized by ritanserin (1 mg/kg, s.c.). Scatchard plots of specific [3H]PCP and [3H]ketanserin binding showed that sulfhydryl-modifying reagent, N-ethylmaleimide (NEM, 100 microM) caused a significant decrease in Bmax without changing Kd. PCP (10 microM) and ritanserin (1 microM) protected [3H]PCP and [3H]ketanserin binding sites from the decrease in the number induced by NEM (100 microM). 5-HT protected [3H]5-HT binding sites from inactivation by NEM, but PCP and ritanserin did not show any effect. On the basis of the present findings, it is concluded that PCP can interact with 5-HT2 receptors directly or allosterically, and 5-HT2 receptors may locate at PCP binding sites in membranes.
我们研究了选择性5-羟色胺2(5-HT2)受体拮抗剂利坦色林是否能拮抗苯环利定(PCP)诱导的大鼠头部抽搐,以证实5-羟色胺能神经元参与PCP的作用,并探究PCP是否能保护[3H]PCP和[3H]酮色林的结合位点免受影响巯基的蛋白质修饰试剂的抑制作用。PCP(7.5、10和12.5毫克/千克,腹腔注射)诱导的头部抽搐被利坦色林(1毫克/千克,皮下注射)完全拮抗。特异性[3H]PCP和[3H]酮色林结合的Scatchard图显示,巯基修饰试剂N-乙基马来酰亚胺(NEM,100微摩尔)导致Bmax显著降低,而Kd不变。PCP(10微摩尔)和利坦色林(1微摩尔)保护[3H]PCP和[3H]酮色林结合位点免受NEM(100微摩尔)诱导的数量减少。5-羟色胺保护[3H]5-羟色胺结合位点免受NEM的失活作用,但PCP和利坦色林未显示任何作用。基于目前的研究结果,得出结论:PCP可直接或变构地与5-HT2受体相互作用,且5-HT2受体可能位于细胞膜中的PCP结合位点处。